Last reviewed · How we verify
Brimonidine Tartrate 0.025% Oph Soln — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Brimonidine Tartrate 0.025% Oph Soln (Brimonidine Tartrate 0.025% Oph Soln) — Uptown Eye Specialists.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Brimonidine Tartrate 0.025% Oph Soln TARGET | Brimonidine Tartrate 0.025% Oph Soln | Uptown Eye Specialists | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Brimonidine Tartrate 0.025% Oph Soln CI watch — RSS
- Brimonidine Tartrate 0.025% Oph Soln CI watch — Atom
- Brimonidine Tartrate 0.025% Oph Soln CI watch — JSON
- Brimonidine Tartrate 0.025% Oph Soln alone — RSS
Cite this brief
Drug Landscape (2026). Brimonidine Tartrate 0.025% Oph Soln — Competitive Intelligence Brief. https://druglandscape.com/ci/brimonidine-tartrate-0-025-oph-soln. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab